在非小细胞肺癌中向EGFR纳米疗法
Andreea Crintea1, Anne-Marie Constantin2, Alexandru C Motofelea3
1Department of Molecular Sciences, University of Medicine and Pharmacy "Iuliu Hațieganu", 400349 Cluj-Napoca, Romania.
Journal of functional biomaterials
|September 27, 2023
概括
向的表皮生长因子受体 (EGFR) 纳米疗法在非小细胞肺癌 (NSCLC) 方面表现有前途. 纳米粒子减少了小鼠的瘤生长,这表明了NSCLC的潜在新治疗途径.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症死亡的主要原因.
- 目前对NSCLC的治疗疗法有效性有限,需要新的治疗方法.
研究的目的:
- 审查表皮生长因子受体 (EGFR) 向纳米治疗NSCLC治疗的潜力.
- 在临床前NSCLC模型中评估EGFR向纳米颗粒的疗效.
主要方法:
- 在NSCLC的EGFR向纳米疗法研究的文献综述.
- 从研究纳米粒子吸收和瘤减少的小鼠模型中分析数据.
主要成果:
- 针对EGFR的纳米颗粒被NSCLC细胞有效地内化.
- 在用这些纳米颗粒治疗的小鼠模型中观察到瘤生长的显著减少.
结论:
- 向EGFR纳米疗法为NSCLC提供了一个有希望的,创新的治疗策略.
- 需要进一步的研究来优化纳米粒子设计,并评估临床安全性和有效性.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


